share_log

HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target

Benzinga ·  Mar 19 10:59

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 274

Recommended

Write a comment